[Efficacy of the triple therapy in the eradication of H. pylori in peptic ulcer].
Boixeda de Miquel
D
D
D000658:Amoxicillin / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D000897:Anti-Ulcer Agents / Q000008:administration & dosage*; D017291:Clarithromycin / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000150:complications / Q000188:drug therapy; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D009853:Omeprazole / Q000008:administration & dosage; D010406:Penicillins / Q000008:administration & dosage; D010437:Peptic Ulcer / Q000150:complications / Q000188:drug therapy*; D013276:Stomach Ulcer / Q000150:complications / Q000188:drug therapy; D013997:Time Factors; D014011:Tinidazole / Q000008:administration & dosage
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D010406:Penicillins; D014011:Tinidazole; D000658:Amoxicillin; D017291:Clarithromycin; D009853:Omeprazole
Eficacia de las terapias triples en la erradicación de H. pylori en la úlcera péptica.